Top Markets
Coin of the day
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Classement en actions #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Prix de l'action
$5.34
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$2.59M
Changement (1 jour)
-11.00%
Changement (1 an)
313.95%
Pays
US
Échange Jupiter Neurosciences, Inc. (JUNS)

Catégorie

Historique des divisions d’actions pour Jupiter Neurosciences, Inc. (JUNS)
L’action Jupiter Neurosciences, Inc. (symbole : JUNS) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 15, 2026.
Une action JUNS achetée avant le Aug 15, 2026 équivaudrait aujourd’hui à 0 actions JUNS.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE